Table 5.
Site | Constrained MD splitting of methyl-pregnenediol (kHz) | Constrained MD splitting of cholesterol (kHz) | Experimental NMR splitting (kHz) |
---|---|---|---|
H2a | −101.5 | −101.4 | 101.68 |
H2e | −66.7 | −67.7 | 67.86 |
H3_1 | −107.1 | −106.7 | 107.30 |
H4e | −63.2 | −62.3 | 62.68 |
H4a | −94.3 | −93.0 | 94.98 |
H6 | −7.29 | −6.69 | 6.44 |
H7a | −92.9 | −95.4 | 96.12 |
H7e | −91.6 | −91.3 | 91.48 |
C18–CD3 | −33.0 | −33.8 | |
C19–CD3 | −37.5 | −34.7 | |
H1a | −104.2 | −99.2 | |
H1e | −69.4 | −46.1 | |
H8_1 | −107.0 | −100.3 | |
H9_1 | −112.6 | −103.0 | |
H11a | −106.4 | −102.7 | |
H11e | −50.7 | −74.7 | |
H12a | −46.4 | −13.1 | |
H12e | −103.1 | −101.1 | |
H14_1 | −103.4 | −100.3 | |
H15_1 | −102.1 | −81.8 | |
H15_2 | −93.5 | −88.9 | |
H16_1 | −17.6 | −40.9 | |
H16_2 | −23.1 | −27.6 | |
H17_1 | −85.7 | −92.7 |